Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

PharmaCyte Biotech, Inc. (NVLX) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsApr-30-22Apr-30-21Apr-30-20Apr-30-19Apr-30-18Apr-30-17Apr-30-16Apr-30-15
Revenues0.00.00.00.00.00.00.00.0
Cost of goods sold1.51.41.61.62.22.01.96.5
Gross profit-1.5-1.4-1.6-1.6-2.2-2.0-1.9-6.5
            Gross margin        
Sales and marketing       0.2
Research and development0.70.90.30.52.01.21.43.5
General and administrative1.91.01.61.72.41.22.73.0
EBIT-4.4-3.6-3.8-4.1-7.0-4.4-6.1-13.3
            EBIT margin        
Pre-tax income-4.2-3.6-3.8-4.1-6.8-4.4-6.1-9.9
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-4.2-3.6-3.8-4.1-6.8-4.4-6.1-9.9
            Net margin        
 
Diluted EPS($0.27)($2.45)($4.23)$0.00($0.01)($0.01)($0.01)($0.01)
Shares outstanding (diluted)15.51.40.91,100.1968.6845.3752.4704.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy